Rare diseases
Investigational molecules
Locations
Back to Sweden376 clinical trials in Gothenburg, Sweden across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)SwedenStudy of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery
SwedenStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
SwedenStudy on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors
SwedenStudy on Stopping Rituximab vs. Continuing Rituximab for Patients with ANCA-Associated Vasculitis in Stable Remission
SwedenStudy on the Safety and Effects of Sparsentan for Children with Proteinuric Kidney Diseases
SwedenStudy of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer
SwedenStudy of Pemigatinib and Retifanlimab for Patients with Advanced Dedifferentiated Liposarcoma
SwedenStudy on the Effectiveness of Belumosudil and Azithromycin for Adults with Chronic Lung Rejection After Lung Transplant
SwedenStudy on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings
SwedenStudy on Treating Acute Myeloid Leukemia in Children and Adolescents Using Gemtuzumab Ozogamicin and a Drug Combination
SwedenStudy on Long-Term Safety and Effects of DNL310 for Patients with Mucopolysaccharidosis Type II (MPS II)
SwedenThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on innovative treatments for various types of leukemia, including chronic lymphocytic leukemia and acute myeloid leukemia. Studies are evaluating new therapeutic combinations and treatment approaches for lymphoma and pediatric cancers.
Advanced research into targeted therapies and personalized treatment protocols for better patient outcomes.
Groundbreaking studies on rare genetic conditions including Niemann-Pick disease and gangliosidoses. Research focuses on evaluating novel treatments and investigating long-term outcomes for mucopolysaccharidosis and other rare disorders.
Innovative approaches to addressing complex rare diseases with targeted therapeutic interventions.
Comprehensive research into cardiovascular disease prevention and treatment, alongside studies on various kidney conditions. Trials evaluating new medications for stroke prevention in atrial fibrillation and treatments for glomerular diseases.
Focus on developing effective treatments for both common and rare cardiovascular and renal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
